The goal of this work is to understand the genetic and molecular mechanisms leading to disorders that affect the adrenal cortex, with emphasis on those that are developmental, hereditary and associated with adrenal hypoplasia or hyperplasia, multiple tumors and abnormalities in other endocrine glands (especially the pituitary gland and to a lesser extent the thyroid gland). We have studied congenital adrenal hypoplasia caused by triple A syndrome and other defects, other multiple endocrine deficiencies, familial hyperaldosteronism, adrenocortical and thyroid cancer, pituitary tumors and multiple endocrine neoplasia (MEN) syndromes affecting the pituitary, thyroid and adrenal glands, and Carney complex (CNC), an autosomal dominant disease. CNC is a MEN syndrome affecting the pituitary, adrenal cortex, thyroid, and the gonads, and is associated with a variety of other tumors, including myxomas and schwannomas, and skin pigmentation defects (lentigines, cafe-au-lait spots, and nevi). We have identified the regulatory subunit type 1-A of protein kinase A (PKA), which is coded by the PRKAR1A gene as the gene responsible for most CNC patients. Thus, a significant part of our work is now focused on PKA-stimulated signaling pathways, PKA effects on tumor suppression and/or development, the cell cycle and chromosomal stability. Prkar1a-specific animal models have also been created to address the tumor-promoting effects of this gene and serve as models for possible therapies. In addition, genes that are mutated in patients with CNC-like and other froms of inherited adrenal tumors are being investigated. Most recently, mutations in PRKACA, PRKACB and ARMC5, as well as in phosphodiesterase genes - phosphodiesterase 11A (PDE11A) and PDE8B - were identified in patients with various forms of bilateral adrenocortical hyperplasias. Mouse models of PDE11A and PDE8B deficiency are being studied, and mutations of these genes are being sought in other endocrine tumors. We have also elucidated the causative genetic defects in Carney-Stratakis syndrome (CSS) and we continue our search for genes that are related to tumors that develop in association with CSS and a similar condition (Carney Triad).
| Stratakis, Constantine A (2018) An update on Cushing syndrome in pediatrics. Ann Endocrinol (Paris) 79:125-131 |
| Goudie, Catherine; Hannah-Shmouni, Fady; Kavak, Mahmure et al. (2018) 65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents. Endocr Relat Cancer 25:T221-T244 |
| Lodish, Maya B; Keil, Margaret F; Stratakis, Constantine A (2018) Cushing's Syndrome in Pediatrics: An Update. Endocrinol Metab Clin North Am 47:451-462 |
| Trivellin, Giampaolo; Hernández-Ramírez, Laura C; Swan, Jeremy et al. (2018) An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations. Best Pract Res Clin Endocrinol Metab 32:125-140 |
| Ironside, Natasha; Chatain, Gregoire; Asuzu, David et al. (2018) Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease. Eur J Endocrinol 178:255-263 |
| Settas, Nikolaos; Faucz, Fabio R; Stratakis, Constantine A (2018) Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome. Mol Cell Endocrinol 469:107-111 |
| Mei, Lin; Smith, Steven C; Faber, Anthony C et al. (2018) Gastrointestinal Stromal Tumors: The GIST of Precision Medicine. Trends Cancer 4:74-91 |
| Hernández-Ramírez, Laura C; Stratakis, Constantine A (2018) Genetics of Cushing's Syndrome. Endocrinol Metab Clin North Am 47:275-297 |
| Tatsi, Christina; Boden, Rebecca; Sinaii, Ninet et al. (2018) Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome. Pediatr Res 83:431-437 |
| Tatsi, Christina; Stratakis, Constantine A (2018) Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease. Clin Perinatol 45:103-118 |
Showing the most recent 10 out of 293 publications
